Mayne Therapeutics

Mayne Pharma is an Australian specialty pharmaceutical company focused on commercializing branded and generic medicines, with particular strength in women’s health and dermatology. The company markets products including Nextstellis, Annovera, Bijuva, Imvexxy, Twyneo and Epsolay, and also maintains broader generic and specialty product capabilities in the United States and Australia. In addition to its commercial pharma business, Mayne operates a full-service CDMO focused on oral and topical dosage forms, offering development, analytical testing and commercial manufacturing. Its core capabilities center on formulation, drug delivery, regulatory, and manufacturing expertise rather than discovery-stage biotech R&D. The business has a significant operating footprint in Salisbury South, Australia and a U.S. commercial presence in Raleigh, North Carolina.